The effect of nebivolol on left ventricular hypertrophy in hypertension

被引：8

作者：

Liu, GS

Wang, LY

Van Nueten, L

Ooms, LA

Van Nueten, L

Borgers, M

Van Nueten, L

Janssen, PA

Van Nueten, L

机构：

[1] Janssen Res Fdn, Life Sci, B-2340 Beerse, Belgium

[2] Chinese PLA Gen Hosp, Dept Cardiol, Beijing, Peoples R China

[3] Chinese PLA Gen Hosp, Dept Echocardiog, Beijing, Peoples R China

来源：

CARDIOVASCULAR DRUGS AND THERAPY | 1999年 / 13卷 / 06期

关键词：

hypertension; left ventricular hypertrophy; nebivolol;

D O I：

10.1023/A:1007840123533

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：549 / 551

页数：3

共 10 条

[1] ACE inhibitor ramipril is more effective than the beta-blocker atenolol in reducing left ventricular mass in hypertension. Results of the RACE (ramipril cardioprotective evaluation) study [J].

AgabitiRosei, E ;

Ambrosioni, E ;

DalPalu, C ;

Muiesan, ML ;

Zanchetti, A .

JOURNAL OF HYPERTENSION, 1995, 13 (11) :1325-1334

[2]

COCKCROFT JR, 1995, J PHARMACOL EXP THER, V274, P1067

[3]

CRUICKSHANK JM, 1992, J HUM HYPERTENS, V6, P85

[4] REVERSAL OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS - A METAANALYSIS OF 109 TREATMENT STUDIES [J].

DAHLOF, B ;

PENNERT, K ;

HANSSON, L .

AMERICAN JOURNAL OF HYPERTENSION, 1992, 5 (02) :95-110

[5] NEBIVOLOL INDUCES ENDOTHELIUM-DEPENDENT RELAXATIONS OF CANINE CORONARY-ARTERIES [J].

GAO, YS ;

NAGAO, T ;

BOND, RA ;

JANSSENS, WJ ;

VANHOUTTE, PM .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 (06) :964-969

[6]

HACHAMOVITCH R, 1988, CURR PROB CARDIOLOGY, V13, P369

[7] Transient and sustained impacts of hydroxyl radicals on sarcoplasmic reticulum function: protective effects of nebivolol [J].

Janssen, PML ;

Zeitz, O ;

Hasenfuss, G .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 366 (2-3) :223-232

[8] ASSOCIATION OF CHANGE IN LEFT-VENTRICULAR MASS WITH PROGNOSIS DURING LONG-TERM ANTIHYPERTENSIVE TREATMENT [J].

MUIESAN, ML ;

SALVETTI, M ;

RIZZONI, D ;

CASTELLANO, M ;

DONATO, F ;

AGABITIROSEI, E .

JOURNAL OF HYPERTENSION, 1995, 13 (10) :1091-1095

[9] Nebivolol vs atenolol and placebo in essential hypertension: a double-blind randomised trial [J].

Van Nueten, L ;

Taylor, FR ;

Robertson, JIS .

JOURNAL OF HUMAN HYPERTENSION, 1998, 12 (02) :135-140

[10] PHARMACOLOGICAL AND HEMODYNAMIC PROFILE OF NEBIVOLOL, A CHEMICALLY NOVEL, POTENT, AND SELECTIVE BETA-1-ADRENERGIC ANTAGONIST [J].

VANDEWATER, A ;

JANSSENS, W ;

VANNEUTEN, J ;

XHONNEUX, R ;

DECREE, J ;

VERHAEGEN, H ;

RENEMAN, RS ;

JANSSEN, PAJ .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 11 (05) :552-563

← 1 →